Brigham and Women’s Hospital-led research reports no significant long-term benefit of cocoa flavanol supplementation in preventing age-related macular degeneration (AMD). The paper is published in the journal JAMA Ophthalmology.
AMD is a progressive retinal disease and the most common cause of severe vision loss in adults over age 50. AMD damages the macula, the central part of the retina responsible for sharp, detailed vision. While peripheral sight is typically preserved, central vision loss can impair reading, driving, facial recognition, and other quality of life tasks. Abnormalities of blood flow in the eye are associated with the occurrence of AMD.
Cocoa flavanols are a group of naturally occurring plant compounds classified as flavonoids, found primarily in the cocoa bean. These bioactive compounds have been studied for their vascular effects, including improved endothelial function and enhanced nitric oxide production, which contribute to vasodilation and circulatory health. Previous trials have shown that moderate intake of cocoa flavanols may lower blood pressure, improve lipid profiles, and reduce markers of inflammation, suggesting a role in mitigating cardiovascular and related vascular conditions.